Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. — South Bend, Indiana

Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. is a clinical research site located in South Bend, Indiana, United States 46617.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has participated in 3 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation, Solid Tumor.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northern Indiana Cancer Research Consortium No. Indiana Cancer Res.?

Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. conducted?

Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has 3 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation, Solid Tumor.

Is Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. accredited by Crixeo Health?

Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northern Indiana Cancer Research Consortium No. Indiana Cancer Res.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.